The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genetically engineered NY-ESO-1 specific T cells in HLA-A201+ patients with advanced cancers.
 
Melinda S. Merchant
No Relationships to Disclose
 
Mihaela C. Cristea
No Relationships to Disclose
 
Edward A. Stadtmauer
Consulting or Advisory Role - Adaptimmune
Research Funding - Adaptimmune
 
William D. Tap
Consulting or Advisory Role - Advaxis; Ariad; EMD Serono; Janssen; Plexxikon
Travel, Accommodations, Expenses - Boehringer Ingelheim
Other Relationship - Morphotek
 
Sandra P. D'Angelo
No Relationships to Disclose
 
Stephan A. Grupp
Consulting or Advisory Role - Novartis
 
Tom Holdich
Employment - Adaptimmune
 
Gwendolyn Binder-Scholl
Employment - Adaptimmune
 
Bent K Jakobsen
Employment - Adaptimmune; Immunocore
 
Kunle Odunsi
No Relationships to Disclose
 
Aaron Rapoport
No Relationships to Disclose
 
Crystal Mackall
Research Funding - Neomune
Patents, Royalties, Other Intellectual Property - I am a co-inventor on patents pending for chimeric antigen receptors targeting B7-H3, ALK and CD276.